DavidRSnydmanMDFACP, FIDSA, FAST(He/Him)

PubMed

• 776 citations
  Increasing Mortality Due to End-Stage Liver Disease in Patients with Human Immunodeficiency Virus Infection
  Ioana Bica, Barbara H. McGovern, Rakesh Dhar, David Stone, Katherine McGowan
  Clinical Infectious Diseases. 2001-02-01
• 230 citations
  Cytomegalovirus in solid organ transplant recipients.
  Atul Humar, David R. Snydman
  American Journal of Transplantation. 2009-12-01
• 6 citations
  Antiviral treatment approaches for cytomegalovirus prevention in kidney transplant recipients: A systematic review of randomized controlled trials.
  Amit D. Raval, Kristin Kistler, Yuexin Tang, Yoshihiko Murata, David R. Snydman
  Transplantation Reviews. 2021-01-01

Journal Articles

• Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation  
  Kotton CN, Kumar D, Caliendo AM, Asberg A, Chou S Danziger-Isakov L, Humar A; Transplantation Society International CMV Consensus Group, Transplantation, 1/1/2013
• Symposium in Honor of the Memory of Francis P Tally, MD, Held at Tufts Medical Center and Tufts University School of Medicine, 11 June 2007  
  Snydman DR, Clinical Infectious Disease, 1/1/2010
• Introduction Symposium in Honor of the Memory of Francis P Tally, MD, Held at Tufts Medical Center and Tufts University School of Medicine  
  Snydman DR, Clinical Infectious Disease, 1/1/2010
• Cytomegalovirus prevention strategies: The case for prophylaxis  
  Snydman DR, Amer J Transplantation, 1/1/2009
• Cytomegalovirus prevention strategies: the case for prophylaxis  
  Snydman DR, Am J Transplant, 1/1/2009
• Cytomegalovirus in Solid Organ Transplantation  
  Humar A, Snydman DR, and the AST Infectious Diseases Community of Practice, Am J Transplant, 1/1/2009
• Use of valganciclovir for prevention and treatment of cytomegalovirus disease  
  Snydman DR, Clin Infect Dis, 1/1/2008
• The persistent clinical impact of cytomegalovirus in organ transplantation  
  Snydman DR, Clin Infect Dis, 1/1/2008
• Prophylaxis and treatment of cytomegalovirus disease in recipients of solid organ transplants: current approach and future challenges  
  Puius YA, Snydman DR, Curr Opin Infect Dis, 1/1/2007
• The case for cytomegalovirus prophylaxis in solid organ transplantation  
  Snydman DR, Rev Med Virol, 1/1/2006
• The potential role for iron overload and fungal infection in liver transplantation  
  Snydman DR, Liver Transplantation, 1/1/2006
• Lactobacillus GG: Bacteriology and clinical applications  
  Doron S, Snydman DR, Gorbach SL, Gastroenterology Clinics of North America, 1/1/2005
• Reply to Adler and Eisenstein  
  Mangili A, Bica I, Hamer DH, Snydman DR, Clin Infect Dis, 1/1/2005
• Iron storage indices and risk of bacterial infections in hemodialysis patients  
  Teehan GS, Ruthazer R, Balakrishnan VS, Snydman DR, Jaber BL, Hemodialysis International, 1/1/2004
• Viral prophylaxis in organ transplant patients  
  Slifkin M, Doron S, Snydman DR, Drugs, 1/1/2004
• Screening of donor and recipient prior to solid organ transplantation  
  Avery RK, Snydman DR, Soave R, Amer Soc Transplantation, 1/1/2004
• Reduced acquisition of vancomycin-resistant enterococci: Gown effect or confounding?  
  Golan Y, Snydman DR, Clin Infect Dis, 1/1/2003
• Historical overview of the use of cytomegalovirus hyperimmune globulin in organ transplantation  
  Snydman DR, Transpl Infect Dis, 1/1/2001
• Posttransplant microbiological surveillance  
  Snydman DR, Clin Infect Dis, 1/1/2001
• Epidemiology of infections after solid-organ transplantation  
  Snydman DR, Clin Infect Dis, 1/1/2001
• Blood cultures drawn from indwelling central venous catheters  
  Snydman DR, Ruthazer, R, Ann Intern Med, 1/1/2000
• Transplant Infections  
  Snydman DR, Mayo Clinic Proceedings, 1/1/1999
• Infection in solid organ transplantation  
  Snydman DR, Transpl Infect Dis, 1/1/1998
• Economic impact of piperacillin/tazobactam in the treatment of suspected polymicrobial infections  
  Huse DM, Russell MW, Drowns S, Snydman DR, Hartz SC, JCOM, 1/1/1998
• Update on nosocomial infections: Gram-positive cocci  
  DesJardin JA, Snydman DR, J Critical Illness, 1/1/1998
• Join now to see all

Books/Book Chapters

• Clinical Decision Support: Critical Care Medicine 
  Chapter: Viral Infections. 
  Doron S. and Snydman D.R.Editors: Kellum JA, Fortenberry JD, Fuchs BD, Shaw A.Decision Support in Medicine, LLC, Wilmington, DE2013
• Principals and Practice of Hospital Medicine 
  Chapter: Chapter 187, Peritonitis and intra-abdominal abscess. 
  Page 1565 - 1571Doron S. and Snydman D.R.Editors: McKean S.C., Ross J.J., Dressler D.D., Brotman D.J. and Ginsberg J.S..McGraw Hill, New York, NY2012
• Scheachter’s Mechanisms of Microbial Disease 
  Chapter: Chapter 75, Healthcare-associated infections. 
  Page 747 - 752Snydman D.R. and Doron SEditors: Engleberg NC, Dermody T and DiRita V.Lippincott Williams and Wilkins, Philadelphia, PAEdition 5th,2012
• Transplant Infections 
  Chapter: Risks and Epidemiology of Infections after Heart Transplantation 
  Denofrio D and Snydman DREditors: Raleigh A. Bowden, M.D., Per Ljungman, M.D., PhD., David R. Snydman, M.D., F.A.C.P..Lippincott Williams and Wilkins, Philadelphia, PAEdition 3rd,2010
• Transplant Infections. 
  Editors: Raleigh A. Bowden, M.D., Per Ljungman, M.D., PhD., David R. Snydman, M.D., F.A.C.P..Lippincott Williams and Wilkins, Philadelphia, PAEdition 3rd,2010
• Metronidazole in Antimicrobial Drug Resistance, volume 1, Mechanisms of Drug Resistance 
  Chapter: Mechanism of resistance. 
  Page 223 - 229Dhand A and Snydman DREditors: Douglas L. Mayers.Humana Press, New York, NY2009
• The 2007 Year Book of Medicine. 
  Editors: Jamie S. Barkin, M.D., Seth M. Berney, M.D.., William H. Frishman, M.D., Renee Garrick, M.D., Patrick J. Loehrer, Sr, M.D. Ernest L. Mazzaferrri, M.D., Barbara A. Phillips, M.D., and David R. Snydman, M.D..Mosby Inc., Philadelphia, PA2007
• Schaechter’s Mechanisms of Microbial Disease. 
  Chapter: Chapter 76, Foodborne Diseases 
  Page 719 - 726Snydman DREditors: N. Cary Engleberg, Victor DiRita, Terence S. Dermody.Lippincott Williams & Wilkins, Baltimore, MDEdition 4th,2007
• Schaechter’s Mechanisms of Microbial Disease. 
  Chapter: Chapter 75, Health Care-Associated Infections. 
  Page 713 - 718Snydman DREditors: N. Cary Engleberg, Victor DiRita, Terence S. Dermody.Lippincott Williams & Wilkins, Baltimore, MDEdition 4th,2007
• Schaechter’s Mechanisms of Microbial Disease. 
  Chapter: Chapter 59: Principles of Epidemiology. 
  Page 566 - 571Snydman DREditors: N. Cary Engleberg, Victor DiRita, Terence S. Dermody.Lippincott Williams & Wilkins, Baltimore, MDEdition 4th,2007
• The 2006 Year Book of Medicine. 
  Editors: Jamie S. Barkin, M.D., William H. Frishman, M.D., Renee Garrick, M.D., Patrick J. Loehrer, Sr, M.D. Ernest L. Mazzaferrri, M.D., Barbara A. Phillips, M.D., Michael H. Pillinger, M.D., and David R. Snydman, M.D..Mosby Inc., Philadelphia, PA2006
• The 2005 Year Book of Medicine. 
  Editors: Jamie S. Barkin, M.D., William H. Frishman, M.D., Saulo Klahr, M.D., Patrick J. Loehrer, Sr, M.D. Ernest L. Mazzaferrri, M.D., Barbara A. Phillips, M.D., Michael H. Pillinger, M.D., and David R. Snydman, M.D..Mosby Inc., Philadelphia, PA2005
• Disease and Therapy Vol. 33 
  Chapter: Antibiotic Optimization: Concepts and Strategies in Clinical Practice. 
  Snydman DR, Lawrence KREditors: Robert C. Owens, Jr., Paul G. Ambrose, and Charles H. Nightingale.Marcel Dekker, New York, NY2005
• Infectious Diseases 
  Chapter: Immune Globulin Therapy (Passive Immunization) for Augmentation of the Host Response 
  Page 358 - 370Griffiths JK, Snydman DREditors: S.L. Gorbach, J.G. Bartlett, and N.R. Blacklow.Lippincott Williams & WilkinsEdition 3rd,2004
• The 2004 Year Book of Medicine. 
  Editors: Jamie S. Barkin, M.D., William H. Frishman, M.D., Saulo Klahr, M.D., Patrick J. Loehrer, Sr, M.D., Ernest L. Mazzaferrri, M.D., Barbara A. Phillips, M.D., Michael H. Pillinger, M.D., and David R. Snydman, M.D..Mosby Inc., Philadelphia, PA2004
• Infectious Diseases 
  Chapter: Food Poisoning 
  Page 689 - 701Hamer DH, Snydman DREditors: S.L. Gorbach, J.G. Bartlett, and N.R. Blacklow.Lippincott Williams & WilkinsEdition 3rd,2004
• Transplant Infections 
  Chapter: Clinical Applications of Immunoglobulin in Hemopoetic Stem Cell or Solid Organ Transplantation. 
  Page 667 - 683Snydman DREditors: Bowden RA, Ljungman P, Paya CV.Lippincott Williams, and Wilkins, Philadelphia, PA2003
• The 2003 Year Book of Medicine. 
  Editors: Jamie S. Barkin, M.D., William H. Frishman, M.D., Saulo Klahr, M.D., Patrick J. Loehrer, Sr, M.D. Ernest L. Mazzaferrri, M.D., Barbara A. Phillips, M.D., Michael H. Pillinger, M.D., and David R. Snydman, M.D..Mosby Inc., Philadelphia, PA2003
• Mosby's Color Atlas and Text of Infectious Disease. 
  Christopher P. Conlon, MA, MD, FRCP, David R. Snydman, M.D.Mosby-Year Book, Incorporated2000
• Infectious Diseases 
  Chapter: Erysipelothrix rhusiopathiae. 
  Page 1755 - 1758Nerad JL, Snydman DREditors: S.L. Gorbach, J.G. Bartlett, and N.R. Blacklow.W.B. SaundersEdition 2nd,1998
• The 1998 Year Book of Infectious Diseases. 
  Editors: Gerald T. Keusch, M.D. ; Assoc Eds: Michael J. Barza, M.D., Michael L. Bennish, M.D., Debra D. Poutsiaka, M.D., Ph.D., Paul R. Skolnik, M.D., David R. Snydman, M.D..Year Book Medical Publishers, Inc., Chicago, IL1998
• Infectious Diseases 
  Chapter: Food poisoning. 
  Page 768 - 781Snydman DREditors: S.L. Gorbach, J.G. Bartlett, and N.R. Blacklow.W.B. SaundersEdition 2nd,1998
• Infectious Diseases 
  Chapter: Miscellaneous gram-negative bacilli: acinetobacter, cardiobacterium, actinobacillus, chromobacterium, capnocytophaga, and others. 
  Page 1871 - 1887Nerad JL, Seville MT, Snydman DREditors: S.L. Gorbach, J.G. Bartlett, and N.R. Blacklow.W.B. SaundersEdition 2nd,1998
• Infectious Diseases 
  Chapter: Serum therapy and augmentation of the hospital response. 
  Page 390 - 407Griffith JK, Snydman DREditors: S.L. Gorbach, J.G. Bartlett, and N.R. Blacklow.W.B. SaundersEdition 2nd,1998
• Mechanisms of Microbial Disease. 
  Chapter: Chapter 56: Principles of Epidemiology. 
  Page 513 - 518Snydman DREditors: Schaechter M, Engleberg NC, Eisenstein BI, Medoff G.Williams and Wilkins, Baltimore, MDEdition 3rd,1998
• Join now to see all

Abstracts/Posters

• D-1151 - Antibiotic Resistance among Bacteroides spp. And Evolving Multidrug-Resistance.
  D.R. Snydman, 54th Interscience Conference on Antimicrobial Agents and Chemotherapy ICAAC, Washington, DC, 9/5/2014
• In Vitro Activity of Surotomycin Tested Against 885 Isolates of Clostridium difficile Collected as part of a National Surveillance Program 2011-2012.
  D.R. Snydman, L.A. McDermott, N.V. Jacobus, S.G. Jenkins, E.J.C. Goldstein, R. Patel, B.A. Forbes, S. Mirrett, D.W. Hecht, R. Goering, C. Thorpe, 54th Interscience Conference on Antimicrobial Agents and Chemotherapy ICAAC, Washington, DC, 9/5/2014
• T-2031- Cost Burden of Cytomegalovirus (CMV) Disease Among Solid Organ Transplant Recipients.
  H. Yang, D. Zhuo, Z. Zhou, E. Q. Wu, P. Chaudhari, D. R. Snydman, 54th Interscience Conference on Antimicrobial Agents and Chemotherapy ICAAC, Washington, DC, 9/5/2014
• K-656-Iron-Related Markers May Predict Infection After Liver Transplantation.
  J. Chow, R. Ruthazer, M. Simpson, F. Gordon, E. Pomfret, M. Westerman, T. Ganz, D. R. Snydman, 54th Interscience Conference on Antimicrobial Agents and Chemotherapy ICAAC, Washington, DC, 9/5/2014
• CMV viral burden is Associated with Severity of CMV Disease and Mortality Outcomes in Solid Organ Transplantation.
  J.M. McBride, J. Jiang, N. Lewin-Koh, B. Feierbach, X. Wu, B.G. Werner, D.R. Snydman, 54th Interscience Conference on Antimicrobial Agents and Chemotherapy ICAAC, Washington, DC, 9/5/2014
• T-470-Peritransplant Lymphopenia and Early Severe Recurrence of Hepatitis C Disease after Liver Transplantation.
  K. M. Johnson, J. K. Chow, N. N. Nierenberg, L. Price, R. Rohrer, R. Freeman, H. M. Lee, F. Askarian, D. R. Snydman, 54th Interscience Conference on Antimicrobial Agents and Chemotherapy ICAAC, Washington, DC, 9/5/2014
• Two Years of Surveillance for the Susceptibility and Epidemiology of Clostridium difficile Associated Diarrheal Isolates (Poster #C1-051).
  D.R. Snydman, L.A. McDermott, N.V. Jacobus, S. Stone, I. Mahoney, S. Jenkins, E.J.C. Goldstein, R. Patel, B.A. Forbes, C. Thorpe, L. Harrell, B. Reller and D. Hecht, 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy ICAAC, Denver, CO, 9/10/2013
• Is Valganciclovir as Effective as Oral Ganciclovir Plus CMV Immune Globulin in Prevention of CMV Disease Following Liver Transplantation (Slide Presentation #T-345).
  N.E. Nierenberg, B. Alraddadi, D.D. Poutsiaka, J.K. Chow, R.J. Rohrer, J.T. Cooper, R.B. Freeman, D.R. Snydman, 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy ICAAC, Denver, CO, 9/10/2013
• Functional Dynamics of the Elderly Gut Microbiome During Probiotic Consumption.
  Emiley Eloe-Fadrosh, PhD, Arthur Brady, PhD, Miriam Haverkamp, MD, Anne-Marie Fiorino, MS, Christine Botelho, MPH, Irina Andreyeva, MD, Linda T. Wang, MD, Lisa Davidso..., Probiotics, Prebiotics and the Host Microbiome: The Science of Translation, New York Academy of Science, 6/12/2013
• Safety of LGG Probiotic in Healthy, Elderly Subjects.
  Linda T. Wang, MD, Lauren Kleimola, MPH, Anne-Marie Fiorino, MS, Christine Botelho, MPH, Irina Andreyeva, MS, Lisa Davidson, MD, Miriam Haverkamp, MD, David Snydman, M..., Probiotics, Prebiotics and the Host Microbiome: The Science of Translation, New York Academy of Science, 6/12/2013
• The Fecal Microbiota of Patients Colonized by Vancomycin-resistant Enterococcus (VRE) Given Lactobacillus GG (LGG) or Placebo.
  Shira Doron, MD, MS, Emiley Eloe-Fadrosh, PhD, David Rasko, PhD, Patricia L. Hibberd, MD, PhD, David R. Snydman, MD, Probiotics, Prebiotics and the Host Microbiome: The Science of Translation, New York Academy of Science, 6/12/2013
• Relationship of Serum Iron Markers to Infection After Liver Transplantation.
  Jennifer Chow, MD, MS, David R. Snydman, MD, FACP, Mary Ann Simpson, PhD, Mark Westerman, PhD, Tomas Ganz, MD, PhD, Fifth Meeting of the International BioIron Society, University College, London, UK, 4/14/2013
• Recurrence of C. difficile infection (CDI): A risk-stratified analysis of Fidaxomicin vs Vancomycin.
  Basem Alraddadi, MBBS, Lauren Epstein, MD, David Snydman, MD, FIDSA, Yoav Golan, MD MS, ID Week-A Joint Meeting of IDSA, SHEA, HIVMA and PIDS, San Diego, CA, 10/17/2012
• A national survey of Outpatient Parenteral Anti-microbial Therapy (OPAT) practices in the United States – Focus on patient safety.
  Eavan Muldoon, MB, BCh, MD, Karen Switkowski, MS, MPH, Alan Tice, MD, FACP, FIDSA, David Snydman, MD, FIDSA, Geneve Allison, MD, ID Week-A Joint Meeting of IDSA, SHEA, HIVMA and PIDS, San Diego, CA, 10/17/2012
• The Impact of Cefepime as First Line Therapy for Neutropenic Fever on Clostridium difficile rates among Hematologic and Oncologic Patients.
  Eavan Muldoon, MB, BCh, MD, Lauren Epstein, MD, Tanya Logvinenko, Susan Murray, Shira Doron, MD, David Snydman, MD, ID Week-A Joint Meeting of IDSA, SHEA, HIVMA and PIDS, San Diego, CA, 10/17/2012
• Antibiotic-Resistance and Carbapenem-Resistant Enterobacteriaceae (CRE): Assessment of Clinical Knowledge and Practices in Non-Infectious Disease Trained Clinicians in...
  Evangeline Thibodeau, MD, MPH, Shira Doron, MD, Vito Iacoviello, MD, Jennifer Schimmel, MD, David Snydman, MD, FIDSA, ID Week-A Joint Meeting of IDSA, SHEA, HIVMA and PIDS, San Diego, CA, 10/17/2012
• Baseline Lymphopenia Predicts Invasive Infections after Orthotopic Liver Transplantation.
  Natalie Nierenberg, MD, MPH, Debra Poutsiaka, MD, PhD, Jennifer Chow, MD, MS, Lori Lyn Price, MS, Richard Freeman, MD, Jeffrey Cooper, MD, Richard Rohrer, MD, David Sn..., ID Week-A Joint Meeting of IDSA, SHEA, HIVMA and PIDS, San Diego, CA, 10/17/2012
• A US Based National Sentinel Surveillance Study for the Susceptibility and Epidemiology of Clostridium difficile Associated Diarrheal Isolates.
  Snydman DR, McDermott LA, Jacobus NV, Goldstein EJC, Harrell L, Patel R, Jenkins S, Johnson S, Gerding D, 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy ICAAC, San Francisco, CA, 9/19/2012
• US National Survey on the Susceptibility of Bacteroides fragilis: Resistance by Species and Centers for the Years 2006-2010.
  Snydman DR, Jacobus NV, McDermott, LA, Harrell L, Hecht D, Venezia R, Patel R, Rosenblatt J, Jenkins S, Goldstein EJC, Newton D, Pierson C, 11th Biennial Congress of the Anaerobe Society of the Americas, San Francisco, CA, 6/29/2012
• Reverse Line Blot Assay for Rapid Detection of Bacterial Agents of Infective Endocarditis in Clinical Samples.
  A.K. Jain, K. Hennessy D. Snydman, S. Doron, L. Perry, N.X. Krueger, A.E. Levin, American Society for Microbiology International Meeting, San Francisco, CA, 6/16/2012
• Activity of Ceftolozane/tazobactam (FORMERLY CXA-201) against a Broad Spectrum of Recent Clinical Anaerobic Isolates.
  Snydman DR, Jacobus NV, McDermott LA, 22nd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), London, United Kingdom, 3/31/2012
• Multiplexed Reverse Line Blot Assay for Rapid Detection of Bacterial Antibiotic Resistance in Suspected Pneumonia Patients.
  A. Jain, S. Shekar, K. Hennessy, C.S. Furniss, D.R. Snydman, S. Doron, L. Perry, N.X. Krueger, A.E. Levin, American Society for Microbiology International meeting, New Orleans, LA, 5/22/2011
• Activity of a Novel Cyclic Lipopeptide, CB-183,315 against gram positive Aerobic and anaerobic enteric isolates, including Vancomycin- resistant enterococci and C. dif...
  D.R. Snydman, N.V. Jacobus, L.A. McDermott, 21st European Society of Clinical Microbiology and Infectious Diseases (ECCMID) /27th ICC, Milan, Italy, 5/1/2011
• Rapid Detection of Fungal Pathogens in Clinical Samples by Reverse Line Blot Assay.
  A. Jain, S. Shekar, K. Hennessy, C.S. Furniss, B. Washburn, D.R. Snydman, S. Doron, L. Perry, N.X. Krueger, A.E. Levin, As Tec 2 workshop, 11/1/2010
• Activity of a Novel Cyclic Lipopeptide, CB-183,315 Against Gram Positive Anaerobic Organisms, Including C. difficile With Elevated MICs Against Metronidazole, Moxiflox...
  D.R. Snydman, N.V. Jacobus, L.A. McDermott, 50th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, Boston, MA, 9/12/2010
• Join now to see all

Other

• State-of-the-Art Management of CMV Infection and Disease in Transplant Recipients. CME slide kit, CD Rom, and web site for education. 
  David R. Snydman and Robert H. Rubin, Synermed Coomunications and the Dannemiller Memorial Education Foundation
  http://www.cmvlink.com
  1/1/2006
• Hypogammaglobulinemia in organ transplantation 2005. A continuing education program sponsored by Tufts University. 
  David R. Snydman, Robin K. Avery, Shira Doron, Arthur R. Rabson, Mohamad H. Yamani, Bramnick and Associates, New York, NY
  1/1/2005
• Transplantation Related Infections 
  Snydman DR, Tufts University School of Medicine
  1/1/2000
• Progress in Prevention of CMV Disease in Solid Organ Transplantation 
  Snydman DR, Tufts University School of Medicine
  1/1/1998
• Cost Effective Antibiotic Utilization 
  Snydman DR, Tufts University School of Medicine
  1/1/1992
• Gram Negative Resistance. 
  Snydman DR, MediCine International
  1/1/1991
• New Developments in CMV Management 
  Snydman DR, Tufts University School of Medicine
  1/1/1991
• Join now to see all